Clinical trials
Hypertension trials in Tunisia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 5 |
| University of Monastir | 4 |
| Dacima Consulting | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| awatef Sassi | 2 |
| Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose | 1 |
| General Administration of Military Health, Tunisia | 1 |
| Les Laboratoires des Médicaments Stériles | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 20 |
| Diabetes Mellitus | 4 |
| Dyslipidemias | 2 |
| Hypertriglyceridemia | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.